1. |
Forlenza GP, Rewers M. The epidemic of type 1 diabetes: what is it telling us? Curr Opin Endocrinol Diabetes Obes 2011; 18:248-51.
|
2. |
Chinese Diabetes Society. China guideline for type 1 diabetes diagnosis and treatment. Beijing: People's Medical Publishing House; 2012.
|
3. |
Nitiyanant W, Tandhanand S, Mahtab H, et al. The Diabcare-Asia 1998 study-outcomes on control and complications in type l and type 2 diabetic patients. Curr Med Res Opin 2002; 18:317-27.
|
4. |
Mbanya JC, Motala AA, Sobngwi E, et al. Diabetes in sub-Saharan Africa. Lancet 2010; 375:2254-66.
|
5. |
Li J, Yan J, Luo G, et al. Clinical analysis of 3159 cases type 1 diabetes mellitus in Guangdong province. Chin J Diabetes Mellitus 2013; 3:96.
|
6. |
Zhao L, Lu Z, Yang G, et al. Clinical characteristic analysis of 742 hospitalized cases with type 1 diabetes mellitus. Chin J Diabetes Mellitus 2013; 5:89-93.
|
7. |
Poudel A, Savari O, Striegel DA, et al. Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes. Endocrine 2015; 49:693-702.
|
8. |
Pipeleers D, Chintinne M, Denys B, et al. Restoring a functional beta-cell mass in diabetes. Diabetes Obes Metab 2008; 10:54-62.
|
9. |
Tsai EB, Sherry NA, Palmer JP, et al. The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia 2006; 49:261-70.
|
10 |
Shao H. Islet autoantibodies and HLA gene heterogeneity of type 1 diabetes onset at different ages. Changsha: Central South University; 2010.
|
11 |
Zhang S, Sun Q, Feng K, et a1. Clinical, biochemical, and immunological characteristics of newly diagnosed nonobese diabetic patients aged 18-45 years in China. J Diabetes Complications 2012; 26:40-3.
|
12 |
Canivell S, Gomis R. Diagnosis and classification of autoimmune diabetes mellitus. Autoimmun Rev 2014; 13:403-7.
|
13 |
Liu L, Deng H, Weng JP, et al. Prevalence of diabetes autoantibodies in Chinese adult patients with type 1 diabetes mellitus and its relation with beta cell function. 50th European Association for the Study of Diabetes Annual Meeting, Vienna, September 15-19, 2014.
|
14 |
Hu LP, Gu P, Zhao M. The clinical significance of serum autoantibodies to pancreatic islet in one thousand and four hundreds patients with diabetes. J Mod Lab Med 2006; 21:15-7.
|
15 |
Yang L, Zhou ZG, Huang G, et al. Six-year follow-up of pancreatic beta cell function in adults with latent autoimmune diabetes. World J Gastroenterol 2005; 11: 2900-5.
|
16 |
Ling Z, De Pauw P, Jacobs-Tulleneers-Thevissen D, et al. Plasma GAD65, a marker for early β-cell loss after intraportal islet cell transplantation in diabetic patients. J Clin Endocrinol Metab 2015; 100:2314-21.
|
17 |
Ortqvist E, Brooks-Worrell B, Lynch K, et al. Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity. J Clin Endocrinol Metab 2010; 95:E310-8.
|
18 |
Boettler T, Pagni PP, Jaffe R, et al. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes. J Autoimmun 2013; 44:40-8.
|
19 |
Jones A, Olsen MZ, Perrild HJ, et al. The psychological impact of living with diabetes: descriptive findings from the DAWN2 study in Denmark. Prim Care Diabetes 2016; 10:83-6.
|
20 |
Hapunda G, Abubakar A, van de Vijver F, et al. Living with type 1 diabetes is challenging for Zambian adolescents: qualitative data on stress, coping with stress and quality of care and life. BMC Endocr Disord 2015; 18:15-20.
|